New pain block study for shoulder surgery: does the expensive version work better?
NCT ID NCT05900427
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study looked at two different nerve blocks to manage pain after shoulder replacement surgery. One group received a standard painkiller (bupivacaine), while the other got a mix that included a longer-acting version (liposomal bupivacaine). The goal was to see which approach led to better pain control and less need for opioids in the days after surgery. The study was stopped early and enrolled 78 adults aged 18-90.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSE TOTAL SHOULDER ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NorthShore University HealthSystem
Skokie, Illinois, 60076, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Iodine-coated surgical drapes may cut infection risk in shoulder replacements
- Shoulder surgery showdown: does removing a tiny bone fragment boost recovery?
- Can a smartphone app get you back on your feet faster after shoulder surgery?
- New nerve block aims to slash opioid use after shoulder surgery
- New shoulder surgery spares muscles, aims for faster recovery
- App-Based rehab could replace office visits after shoulder surgery